Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

NR5A2 as pharmacological target for nervous system malignancies

Oct. 7, 2021

Cosegregation powerfully classifies BRCA 1/2 variants

Oct. 7, 2021

TYK Medicines discovers new EGFR and/or HER2 mutant inhibitors

Oct. 6, 2021

Suzhou Kintor Pharmaceuticals discloses new PROTACs

Oct. 6, 2021

Researchers patent new glucose triptolide conjugates

Oct. 6, 2021

Protein mimetic amyloid inhibitor shows antitumor activity in vivo

Oct. 5, 2021

Fochon Pharmaceuticals synthesizes new BTK inhibitors

Oct. 5, 2021

Janpix divulges new STAT5 inhibitors

Oct. 5, 2021

University of Kentucky identifies histone demethylase and Wnt signaling inhibitors

Oct. 5, 2021

Genentech patents new TEAD inhibitors

Oct. 5, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...